ALBERTDAVDPharmaceuticals

Albert David LtdQuarterly Results & Earnings

587.05
-6.71%
Profit Growth YoY-118.26%Latest quarter
Sales Growth YoY-11.38%Latest quarter
Sales CAGR 5Y1.52%5 year compound
Profit CAGR 5Y-2.13%5 year compound
📋

Quarterly Performance

YoY Profit Growth-118.26%
🔴 Significant decline
YoY Sales Growth-11.38%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
9.63%
EPS Growth 5Y
-2.13%
Interest Coverage
Higher = safer debt servicing
-9.33
ROE
4.39%
ROCE
6.45%
💡

Growth Analysis

Albert David Ltd reported YoY profit growth of -118.26% and revenue growth of -11.38% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 1.52% and profits at -2.13% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.